Chandra Bhagat Pharm Stock Price Analysis and Quick Research Report. Is Chandra Bhagat Pharm an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Chandra Bhagat Pharm. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Chandra Bhagat Pharm has a PE ratio of 48.1598873041028 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Chandra Bhagat Pharm has ROA of 1.885% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Chandra Bhagat Pharm has a Current ratio of 1.378.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Chandra Bhagat Pharm has a ROE of 5.7338%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Chandra Bhagat Pharm has a Debt to Equity ratio of 0.5938 which means that the company has low proportion of debt in its capital.

• Sales growth: Chandra Bhagat Pharm has reported revenue growth of 84.9819% which is fair in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Chandra Bhagat Pharm for the current financial year is -3.250909442436%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Chandra Bhagat Pharm is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Chandra Bhagat Pharm is Rs 1.1358. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Chandra Bhagat Pharm in Ticker for free. Also, one can get the intrinsic value of Chandra Bhagat Pharm by using Valuation Calculators, which are available with a Finology ONE subscription. 

Chandra Bhagat Pharm FAQs

Q1. What is Chandra Bhagat Pharm share price today?
Ans: The current share price of Chandra Bhagat Pharm is Rs 54.7.

Q2. What is the market capitalisation of Chandra Bhagat Pharm?
Ans: Chandra Bhagat Pharm has a market capitalisation of Rs 41.27145632 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Chandra Bhagat Pharm?
Ans: The PE ratio of Chandra Bhagat Pharm is 48.1598873041028 and the P/B ratio of Chandra Bhagat Pharm is 1.37713651274795, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Chandra Bhagat Pharm share?
Ans: The 52-week high share price of Chandra Bhagat Pharm is Rs 85.5, and the 52-week low share price of Chandra Bhagat Pharm is Rs 46.15.

Q5. Does Chandra Bhagat Pharm pay dividends?
Ans: Currently, Chandra Bhagat Pharm does not pay dividends. Dividend yield of Chandra Bhagat Pharm is around 0%.

Q6. What are the face value and book value of Chandra Bhagat Pharm shares?
Ans: The face value of Chandra Bhagat Pharm shares is Rs 10, while the book value per share of Chandra Bhagat Pharm is around Rs 39.7201. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Chandra Bhagat Pharm?
Ans: Chandra Bhagat Pharm has a total debt of Rs 16.4268 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Chandra Bhagat Pharm?
Ans: The ROE of Chandra Bhagat Pharm is 5.7338% and ROCE of Chandra Bhagat Pharm is 8.2234%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Chandra Bhagat Pharm a good buy for the long term?
Ans: The Chandra Bhagat Pharm long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Chandra Bhagat Pharm undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Chandra Bhagat Pharm appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Chandra Bhagat Pharm’s financials?
Ans: You can review Chandra Bhagat Pharm’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.